|
From ICER’s President and CEO Sarah K. Emond, MPP:
This week, ICER hosted a public meeting on the clinical and cost effectiveness of Covid-19 vaccines. A special thank you to all the organizations that participated in yesterday’s meeting, including: the National Health Council, AARP, AHIP, the American Pharmacists Association, the Patient Advocate Foundation, and the New York State Department of Health. We also want to thank the New England CEPAC, an independent committee comprised of experts across health policy, health economics, patient advocacy, evidence-based medicine, and clinical research, for a fruitful discussion around the findings of the ICER report.
Coming out of the ICER public meeting, many stakeholders agreed that the current confusion around vaccine policy is alarming. Our health care system works best when public health officials have access to independent experts who can evaluate the data on the effectiveness of medical interventions, like vaccines, so that those officials can make clear recommendations for the public. For 20 years, ICER has provided evidence-based analyses on how well therapies work for patients. And for 20 years, policymakers have been using our public and transparent analyses to inform recommendations that support both individual and public health.
If you missed the June 25th public meeting, a recording of the meeting will be available for viewing next week on ICER’s website. The Final Evidence Report will be published on July 28th and include a full summary of the public meeting and resulting policy recommendations.
|